- Home
- THFF vs TERN Comparison
THFF vs TERN Comparison
Compare THFF & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- TERN
- Stock Information
- Founded
- THFF 1984
- TERN 2017
- Country
- THFF United States
- TERN United States
- Employees
- THFF N/A
- TERN N/A
- Industry
- THFF Major Banks
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- THFF Finance
- TERN Health Care
- Exchange
- THFF Nasdaq
- TERN Nasdaq
- Market Cap
- THFF 686.6M
- TERN 634.5M
- IPO Year
- THFF N/A
- TERN 2021
- Fundamental
- Price
- THFF $58.76
- TERN $7.75
- Analyst Decision
- THFF Buy
- TERN Buy
- Analyst Count
- THFF 3
- TERN 6
- Target Price
- THFF $59.50
- TERN $13.99
- AVG Volume (30 Days)
- THFF 46.5K
- TERN 1.1M
- Earning Date
- THFF 10-21-2025
- TERN 11-11-2025
- Dividend Yield
- THFF 3.49%
- TERN N/A
- EPS Growth
- THFF 21.43
- TERN N/A
- EPS
- THFF 5.24
- TERN N/A
- Revenue
- THFF $230,446,000.00
- TERN N/A
- Revenue This Year
- THFF $30.73
- TERN N/A
- Revenue Next Year
- THFF $2.82
- TERN N/A
- P/E Ratio
- THFF $11.16
- TERN N/A
- Revenue Growth
- THFF 19.59
- TERN N/A
- 52 Week Low
- THFF $40.57
- TERN $1.87
- 52 Week High
- THFF $60.77
- TERN $10.70
- Technical
- Relative Strength Index (RSI)
- THFF 56.31
- TERN 63.94
- Support Level
- THFF $56.84
- TERN $7.01
- Resistance Level
- THFF $59.50
- TERN $7.67
- Average True Range (ATR)
- THFF 1.19
- TERN 0.43
- MACD
- THFF -0.23
- TERN -0.03
- Stochastic Oscillator
- THFF 42.56
- TERN 95.84
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.